Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement
- 1 May 2014
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 27 (5), 751-757
- https://doi.org/10.1038/modpathol.2013.199
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growthProceedings of the National Academy of Sciences of the United States of America, 2013
- The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal SarcomasThe American Journal of Surgical Pathology, 2012
- 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcomaProceedings of the National Academy of Sciences, 2012
- The Utility of Discovered on Gastrointestinal Stromal Tumor 1 (DOG1) Antibody in Surgical Pathology—the GIST of ItAdvances in Anatomic Pathology, 2010
- DOG1 Antibody in the Differential Diagnosis of Gastrointestinal Stromal TumorsThe American Journal of Surgical Pathology, 2009
- Expression of platelet‐derived growth factor receptor in low‐grade endometrial stromal sarcomas in the absence of activating mutationsHistopathology, 2007
- The c-kit (CD117) sequence variation M541L, but not N564K, is frequent in the general population, and is not associated with CML in CaucasiansLeukemia, 2005
- Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expressionGynecologic Oncology, 2004
- Endometrial Stromal Sarcomas With Unusual Histologic FeaturesThe American Journal of Surgical Pathology, 2002
- Myxoid and Fibrous Endometrial Stromal Tumors of the UterusInternational Journal of Gynecological Pathology, 1999